FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
BetaShares - Global Healthcare Currency Hedged ETF ETF AnalysisComprehensive ETF analysis for BetaShares - Global Healthcare Currency Hedged ETF (DRUG.AX) including NAV, expense ratio, sector breakdown, and holdings data.ETF AnalysisDRUG.AX
DRUG.AX
BetaShares - Global Healthcare Currency Hedged ETF
DRUG.AX
  1. Home
  2. Screener
  3. BetaShares - Global Healthcare Currency Hedged ETFDRUG.AXETF
BetaShares - Global Healthcare Currency Hedged ETF Logo

BetaShares - Global Healthcare Currency Hedged ETF

ETF
🇦🇺DRUG.AX•ASX•Equity

Your view on DRUG.AX

BetaShares - Global Healthcare Currency Hedged ETF Logo

BetaShares - Global Healthcare Currency Hedged ETF

ETFBetaShares
🇦🇺DRUG.AX•ASX•Equity
AUM (AUD)$171.85M
Expense Ratio0.57%
Holdings0

Sentiment

AUM (AUD)

$171.85M

Expense Ratio

0.57%

Holdings

0

Sentiment

DRUG.AX
BetaShares - Global Healthcare Currency Hedged ETF
DRUG.AX

Overview for BetaShares - Global Healthcare Currency Hedged ETF

Fund Type
ETF
Fund Issuer
BetaShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
August 4, 2016
Domicile
AU
Website
betashares.com.au/fund/global-healthcare-etf-currency-hedged
Fund Type
ETF
Fund Issuer
BetaShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
August 4, 2016
Domicile
AU
Website
betashares.com.au/fund/global-healthcare-etf-currency-hedged
Fund Type
ETF
Fund Issuer
BetaShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
August 4, 2016
Domicile
AU
Website
betashares.com.au/fund/global-healthcare-etf-currency-hedged

About this fund

This ETF seeks to replicate the returns of a specific index (prior to any fees or charges) that comprises prominent global healthcare firms located outside of Australia. Its currency exposure is managed by hedging the investments into Australian dollars.

DRUG.AX Stock Price

Key Facts

Equity

Expense Ratio

0.57%

AUM

$171.85M

Fund Details

NAV$8.87 AUD
Average Volume180.8K
Inception DateAugust 4, 2016
Asset ClassEquity
Fund IssuerBetaShares
DomicileAU
ISINAU00000DRUG1
NAV CurrencyAUD

Expense Ratio

0.57%

Assets Under Management

$171.85M

NAV

$8.87 AUD

Average Volume

180.8K

Inception Date

August 4, 2016

Asset Class

Equity

Fund Issuer

BetaShares

Domicile

AU

ISIN

AU00000DRUG1

NAV Currency

AUD

Expense Ratio

0.57%

Assets Under Management

$171.85M

NAV

$8.87 AUD

Average Volume

180.8K

Inception Date

August 4, 2016

Asset Class

Equity

Fund Issuer

BetaShares

Domicile

AU

ISIN

AU00000DRUG1

NAV Currency

AUD

Data last updated: Sep 19, 2026, 07:12 AM

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

News

Latest Market News

What is DRUG.AX?

BetaShares - Global Healthcare Currency Hedged ETF (DRUG.AX) is a Equity fund from BetaShares, listed since 2016, with $171.8M in assets under management, a 0.57% expense ratio, a NAV of $8.87 AUD.

What's in DRUG.AX? Top 10 holdings

HoldingWeight
Eli Lilly & Co LLY8.15%
Johnson & Johnson JNJ7.85%
Abbvie INC ABBV6.99%
Merck & Co INC MRK5.13%
Unitedhealth Group INC UNH5.06%
Thermo Fisher Scientific INC TMO4.05%
Roche Holding Ag ROP.SW3.96%
Astrazeneca PLC AZN.L3.95%
Novartis Ag NOVN.SW3.79%
Amgen INC AMGN3.11%

DRUG.AX sector breakdown

  • Healthcare 100.00%

Comparable funds

  • BNKS.AXBetaShares - Global Banks Currency Hedged ETF
  • FUEL.AXBetashares Global Energy Companies Currency Hedged ETF
  • HJPN.AXBetaShares - Japan Currency Hedged ETF
  • IKO.AXiShares MSCI South Korea ETF
  • ISO.AXiShares S&P/ASX Small Ordinaries ETF
  • IXI.AXiShares Global Consumer Staples ETF (AU)
  • MNRS.AXBetaShares - Global Gold Miners Currency Hedged ETF
  • NDIA.AXGlobal X India Nifty 50 ETF

More BetaShares ETFs

  • AAA.AXBetaShares - Australian High Interest Cash ETF
  • AGVT.AXBetaShares - Australian Government Bond ETF
  • ARMR.AXBetaShares - Global Defence ETF
  • ASIA.AXBetaShares - Asia Technology Tigers ETF
  • AUDS.AXBetashares Strong Australian Dollar Fund (Hedge Fund)
  • AUST.AXBetaShares - Managed Risk Australian Shares Complex ETF
  • BBOZ.AXBetaShares Australian Equities Strong Bear Complex ETF
  • BBUS.AXBetaShares - US Equities Strong Bear Currency Hedged Complex ETF
  • BEAR.AXBetaShares - Australian Equities Bear Complex ETF
  • BHYB.AXBetaShares - Australian Major Bank Hybrids Index ETF
  • BNDS.AXBetaShares Western Asset Australian Bond Active ETF